Showing 3,821 - 3,840 results of 102,439 for search '(( 50 ((teer decrease) OR (mean decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 3821
  2. 3822
  3. 3823

    Losartan increased ACE-2 expression, while SARS-CoV-2 spike protein decreased ACE-2 expression in hACE2 brains. by Mackenzi Meier (19251139)

    Published 2024
    “…Brain homogenate was assessed for ACE-2 expression. a) RT-PCR analysis showing the effect of Losartan and spike protein on ACE-2 gene expression. …”
  4. 3824
  5. 3825
  6. 3826
  7. 3827
  8. 3828
  9. 3829

    Image1_Reduction of kinesin I heavy chain decreases tau hyperphosphorylation, aggregation, and memory impairment in Alzheimer’s disease and tauopathy models.jpg by Karthikeyan Selvarasu (14004867)

    Published 2022
    “…Here, we reported that the kinesin-I heavy chain (KIF5B), a key molecular motor protein, is involved in tau homeostasis in AD cells and animal models. …”
  10. 3830
  11. 3831
  12. 3832
  13. 3833
  14. 3834

    GluN2A(D731N) enhances sensitivity to endogenous proton and zinc ions. by Kai Gao (120150)

    Published 2017
    “…Di-heteromeric (h2A-D731N), one-copy and two-copy mutant tri-heteromeric (D731N/2A and D731N/D731N) receptors show a decreased current ratio, indicating enhanced proton sensitivity. …”
  15. 3835
  16. 3836
  17. 3837
  18. 3838

    GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

    Published 2017
    “…<p>(<b>A,B</b>) Representative TEVC recordings obtained from oocytes expressing WT GluN1/GluN2A (WT 2A) receptors (<b>A</b>) and GluN1/GluN2A(D731N) (2A-D731N) receptors (<b>B</b>) in which the currents were evoked by increasing concentrations (μM) of glutamate (in the presence of 100 μM glycine) at the holding potential of -40 mV. …”
  19. 3839
  20. 3840

    <i>WDR5</i> Expression Is Prognostic of Breast Cancer Outcome by Xiaofeng Dai (793874)

    Published 2015
    “…<div><p>WDR5 is a core component of the human mixed lineage leukemia-2 complex, which plays central roles in ER positive tumour cells and is a major driver of androgen-dependent prostate cancer cell proliferation. …”